company background image
CGS

Cogstate ASX:CGS Stock Report

Last Price

AU$1.67

Market Cap

AU$289.5m

7D

1.2%

1Y

107.5%

Updated

22 May, 2022

Data

Company Financials +
CGS fundamental analysis
Snowflake Score
Valuation5/6
Future Growth6/6
Past Performance5/6
Financial Health5/6
Dividends0/6

CGS Stock Overview

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally.

Cogstate Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cogstate
Historical stock prices
Current Share PriceAU$1.67
52 Week HighAU$2.68
52 Week LowAU$0.80
Beta-0.038
1 Month Change-25.78%
3 Month Change-4.57%
1 Year Change107.45%
3 Year Change595.83%
5 Year Change75.79%
Change since IPO234.00%

Recent News & Updates

Mar 22
Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital

Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

Oct 20
We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation

We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation

Performance at Cogstate Limited ( ASX:CGS ) has been reasonably good and CEO Brad O'Connor has done a decent job of...

Shareholder Returns

CGSAU Healthcare ServicesAU Market
7D1.2%0.5%1.1%
1Y107.5%-17.1%1.5%

Return vs Industry: CGS exceeded the Australian Healthcare Services industry which returned -17.1% over the past year.

Return vs Market: CGS exceeded the Australian Market which returned 1.5% over the past year.

Price Volatility

Is CGS's price volatile compared to industry and market?
CGS volatility
CGS Average Weekly Movement7.3%
Healthcare Services Industry Average Movement9.3%
Market Average Movement9.5%
10% most volatile stocks in AU Market16.5%
10% least volatile stocks in AU Market4.3%

Stable Share Price: CGS is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: CGS's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999171Brad O'Connorhttps://www.cogstate.com

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The company’s services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments.

Cogstate Fundamentals Summary

How do Cogstate's earnings and revenue compare to its market cap?
CGS fundamental statistics
Market CapUS$203.41m
Earnings (TTM)US$9.76m
Revenue (TTM)US$41.91m

20.8x

P/E Ratio

4.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CGS income statement (TTM)
RevenueUS$41.91m
Cost of RevenueUS$16.84m
Gross ProfitUS$25.07m
Other ExpensesUS$15.30m
EarningsUS$9.76m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Jul 28, 2022

Earnings per share (EPS)0.056
Gross Margin59.82%
Net Profit Margin23.30%
Debt/Equity Ratio2.7%

How did CGS perform over the long term?

See historical performance and comparison
New valuation analysis is now available for all ASX stocks. This is in beta.

Future Growth

How is Cogstate forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

6/6

Future Growth Score 6/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


27.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CGS's forecast earnings growth (27% per year) is above the savings rate (1.8%).

Earnings vs Market: CGS's earnings (27% per year) are forecast to grow faster than the Australian market (6.2% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CGS's revenue (24.8% per year) is forecast to grow faster than the Australian market (4.7% per year).

High Growth Revenue: CGS's revenue (24.8% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CGS's Return on Equity is forecast to be high in 3 years time (27.1%)


Past Performance

How has Cogstate performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


51.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CGS has a large one-off gain of $2.4M impacting its December 31 2021 financial results.

Growing Profit Margin: CGS's current net profit margins (23.3%) are higher than last year (1.2%).


Past Earnings Growth Analysis

Earnings Trend: CGS's earnings have grown significantly by 51% per year over the past 5 years.

Accelerating Growth: CGS's earnings growth over the past year (2812.4%) exceeds its 5-year average (51% per year).

Earnings vs Industry: CGS earnings growth over the past year (2812.4%) exceeded the Healthcare Services industry 10.6%.


Return on Equity

High ROE: CGS's Return on Equity (34.7%) is considered high.


Financial Health

How is Cogstate's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: CGS's short term assets ($37.2M) exceed its short term liabilities ($15.5M).

Long Term Liabilities: CGS's short term assets ($37.2M) exceed its long term liabilities ($8.5M).


Debt to Equity History and Analysis

Debt Level: CGS has more cash than its total debt.

Reducing Debt: Insufficient data to determine if CGS's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: CGS's debt is well covered by operating cash flow (541.3%).

Interest Coverage: CGS's interest payments on its debt are well covered by EBIT (187.3x coverage).


Balance Sheet


Dividend

What is Cogstate current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate CGS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CGS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CGS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CGS's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CGS has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.6yrs

Average management tenure


CEO

Brad O'Connor

16.42yrs

Tenure

US$1,076,087

Compensation

Mr. Bradley O'Connor, also known as Brad, B.Bus, CA, has been the Chief Executive Officer and Managing Director of Cogstate Limited since December 1, 2005 and served as its Chief Financial Officer since Ma...


CEO Compensation Analysis

Compensation vs Market: Brad's total compensation ($USD1.08M) is above average for companies of similar size in the Australian market ($USD560.06K).

Compensation vs Earnings: Brad's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: CGS's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

Experienced Board: CGS's board of directors are considered experienced (6.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Cogstate Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Cogstate Limited
  • Ticker: CGS
  • Exchange: ASX
  • Founded: 1999
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Implied Market Cap: AU$289.469m
  • Shares outstanding: 173.33m
  • Website: https://www.cogstate.com

Number of Employees


Location

  • Cogstate Limited
  • 425 Smith Street
  • Suite 117
  • Fitzroy
  • Victoria
  • 3065
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/22 00:00
End of Day Share Price2022/05/20 00:00
Earnings2021/12/31
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.